Tanya Dorff has joined City of Hope as an associate clinical professor in the Department of Medical Oncology, heading the genitourinary cancers program. She was previously at USC Keck School of Medicine, where she served as an associate professor of clinical medicine in the Department of Medicine.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
